UCB has unveiled plans to invest in a cutting-edge biologics manufacturing facility in the United States. This new site is designed to support the growing needs of U.S. patients and is projected to contribute approximately $5 billion in total economic impact.
The new facility is expected to create around 300 permanent, highly skilled direct jobs in biologics manufacturing and more than 500 jobs during construction. UCB is currently undertaking a comprehensive feasibility study to determine the ideal U.S. location, with a focus on regions that offer strong talent pipelines and innovation ecosystems.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.